Hints and tips:
...Other Bets' line -- a collection of misfit, moonshot investments including self-driving software Waymo, health-data laboratory Verily Sciences and Alphaville favourite, smart-city planner SideWalk Labs...
...The competitive challenge from Google, which acquired smart thermostat maker Nest Labs this year, was one of the factors Mr Teyssen considered....
...Nothing better highlighted these changes than Google’s $3.2bn acquisition in January of Nest Labs, a four-year-old start-up that makes smart thermostats and smoke alarms for the home....
...As well as Ammunition, Leeo’s investors also include energy company Eon, giving it potential access to millions of homes....
...It’s still unclear where companies such as RWE, EON and EDF fit into such a brave new world....
...Its Manchester base will have a virtual reality showroom, development lab and 3D classroom infrastructure....
...Sales at Sandoz, Novartis' generics division, rose 74 per cent to $1.5bn, with the acquisitions of Hexal and Eon Labs adding 72 percentage points to sales growth in local currencies....
...Annual sales surged 54 per cent at Sandoz to $4.7bn, helped by the $1.4bn contribution from Hexal, Germany’s second largest generics maker, and Eon Labs, the US drugmaker, acquired last year in a deal valued...
...Analysts were relieved by a reduction in the forecast integration costs for Hexal and Eon Labs to $175-$250m, compared with a $250-$350m estimate made at Novartis’s half year results in July....
...Integrating Hexal and Eon Labs should boost sales by more than $1bn in the second half....
...Novartis also spent $8.3bn on privately owned Hexal of Germany and Eon Labs, its US affiliate, briefly overtaking Teva Pharmaceutical Industries to become the world’s biggest maker of generic drugs as generic...
...Labs for a combined $8.3bn....
...Novartis is betting on this trend with the acquisition of Hexal, Germany's second biggest generics maker, plus its US offshoot, Eon Labs, for $8.3bn....
...5.65bn ($7.3bn), Novartis will also launch a tender offer for Eon Labs' outstanding shares, for $31 a share, or about $1bn....
...s Novartis to expand its own generics business by buying Hexal of Germany and taking a stake in Eon Labs of the US highlights the growing importance of generic drugs....
...Labs to create the world's biggest generics drugs company ....
...Novartis’ plans to create the world’s largest generics drugmaker with the two-pronged acquisition of Hexal and Eon Labs lifted hopes for further consolidation....
International Edition